ING Groep: I Think I Sold Too Soon – The Stock Still Is A ‘Buy’ (NYSE:ING)
In an article that was published about 3.5 years ago, I argued the Russia fears were overblown and ING Groep ( ING ) appeared to be very cheap. I'm very happy to see that I was right, as the shareThe Investment Doctor is a financial writer, highlighting European small-caps with a 5-7 year investment horizon. He strongly believes a portfolio should consist of a mixture of dividend and growth stocks. He is the leader of the investment group European Small Cap Ideas which offers exclusive access to actionable ...